2.Beckwith–Wiedemann Syndrome Presenting as Persistent Non-Ketotic Hypoglycemia in a Preterm Infant
Wan Nurzahiah Wan Zakaria ; Yee Lin Lee ; Sin Yin Gan ; Tong Wooi Ch&rsquo ; ng ; Zurina Zainudin
Journal of the ASEAN Federation of Endocrine Societies 2026;41(S1):146-
Introduction:
Beckwith–Wiedemann syndrome (BWS) is a congenital
overgrowth disorder associated with dysregulation of
genes on chromosome 11p15.5. Infants with BWS can
present with hyperinsulinemic hypoglycemia. There are
also distinctive clinical features including macrosomia,
macroglossia and visceromegaly that may raise suspicion
of this diagnosis.
Case:
A preterm female infant of 30 weeks gestation with a birth
weight of 1.87 kg (97th centile) had recurrent hypoglycemia
in the neonatal period, requiring escalation to a maximum
glucose infusion rate of 17.6 mg/kg/min. Hypoglycemia
only resolved after starting intravenous glucagon infusion.
Critical sampling during hypoglycemia revealed serum
insulin 3.9 µU/mL (3–25 µU/mL), serum ketone 0.2 mmol/L,
cortisol 3,053 nmol/L and growth hormone 16.2 ng/mL.
These findings supported the diagnosis of non-ketotic
hyperinsulinemic hypoglycemia. She was commenced
on oral diazoxide with resolution of hypoglycemia and
discontinuation of glucagon. Examination at birth revealed macroglossia, hepatomegaly
and ballotable kidneys. An initial US abdomen at birth
revealed bilateral enlarged kidneys but normal liver. An
initial chromosomal study revealed karyotype 46, XX. Over
time, additional clinical features became evident fulfilling
the diagnostic criteria for BWS, that is, polyhydramnios,
large for gestational age, transient hypoglycemia, hyperinsulinism, macroglossia, hemihypertrophy, facial nevi,
bilateral ear creases, hepatomegaly and ballotable kidney.
A repeat US abdomen surveillance at 4 months old revealed
a heterogeneous liver mass with marked vascularity,
prompting a diagnosis of hepatic hemangioma. She was
commenced on oral propranolol, with reduction in the size
and vascularity of the liver hemangioma and decline in
alpha-fetoprotein levels.
Conclusion
The clinical features of BWS may not be recognizable in
a preterm baby in early neonatal period. Careful clinical
examination should be done in a baby with persistent
hyperinsulinemic hypoglycemia for underlying syndromal
causes. US surveillance should also be carried out due to
increased risk of hepatoblastoma or liver hemangioma in
BWS, as was seen in this case.
Infant, Newborn
;
Infant
;
Beckwith-Wiedemann Syndrome
;
Infant, Premature
;
Hypoglycemia
3.Risk factors and prognosis of first extubation failure in neonates undergoing invasive mechanical ventilation.
Mengyao WU ; Hui RONG ; Rui CHENG ; Yang YANG ; Keyu LU ; Fei SHEN
Journal of Central South University(Medical Sciences) 2025;50(8):1398-1407
OBJECTIVES:
Prolonged invasive mechanical ventilation is associated with increased risks of severe complications such as retinopathy of prematurity and bronchopulmonary dysplasia. Although neonatal intensive care unit (NICU) follow the principle of early extubation, extubation failure rates remain high, and reintubation may further increase the risk of adverse outcomes. This study aims to identify risk factors and short-term prognosis associated with first extubation failure in neonates, to provide evidence for effective clinical intervention strategies.
METHODS:
Clinical data of neonates who received invasive ventilation in the NICU of Children's Hospital of Nanjing Medical University from January 1, 2019, to December 31, 2021, were retrospectively collected. Neonates were divided into a successful extubation group and a failed extubation group based on whether reintubation occurred within 72 hours after the first extubation. Risk factors and short-term outcomes related to extubation failure were analyzed.
RESULTS:
A total of 337 infants were included, with 218 males (64.69%). Initial extubation failed in 34 (10.09%) infants. Compared with the successful extubation group, the failed extubation group had significantly lower gestational age [(31.37±5.14) weeks vs (34.44±4.07) weeks], age [2.5 (1.00, 8.25) h vs 5 (1.00, 22.00) h], birth weight [(1 818.97±1128.80) g vs (2 432.18±928.94) g], 1-minute Apgar score (6.91±1.90 vs 7.68±2.03), and the proportion of using mask oxygenation after extubation (21% vs 46%) (all P<0.05). Conversely, compared with the successful extubation group, the failed extubation group had significantly higher rates of vaginal delivery (59% vs 32%), caffeine use during mechanical ventilation (71% vs 38%), dexamethasone use at extubation (44% vs 17%), the highest positive end-expiratory pressure level within 72 hours post-extubation [6(5.00, 6.00) cmH2O vs 5 (0.00, 6.00) cmH2O] (1 cmH2O=0.098 kPa), the highest FiO2 within 72 hours post-extubation [(34.35±5.95)% vs (30.22±3.58)%], and duration of noninvasive intermittent positive pressure ventilation after extubation [0.5 (0.00, 42.00) hours vs 0 (0, 0) hours] (all P<0.05). Multivariate analysis identified gestational age <28 weeks (OR=5.570, 95% CI 1.866 to 16.430), age at NICU admission (OR=0.959, 95% CI 0.918 to 0.989), and a maximum FiO2≥35% within 72 hours post-extubation (OR=4.541, 95% CI 1.849 to 10.980) as independent risk factors for extubation failure (all P<0.05). Additionally, the failed extubation group exhibited significantly higher incidences of necrotizing enterocolitis grade II or above, moderate-to-severe bronchopulmonary dysplasia, severe bronchopulmonary dysplasia, retinopathy of prematurity, treatment abandonment due to poor prognosis, and discharge on home oxygen therapy (all P<0.05). Total hospital length of stay and total hospitalization costs were also significantly increased in the failed extubation group (all P<0.05).
CONCLUSIONS
Gestational age <28 weeks, younger age at NICU admission, and FiO2≥35% after extubation are high-risk factors for first extubation failure in neonates. Extubation failure markedly increases the risk of adverse clinical outcomes.
Humans
;
Infant, Newborn
;
Male
;
Female
;
Airway Extubation/adverse effects*
;
Risk Factors
;
Retrospective Studies
;
Respiration, Artificial/methods*
;
Intensive Care Units, Neonatal
;
Prognosis
;
Gestational Age
;
Bronchopulmonary Dysplasia
;
Infant, Premature
;
Treatment Failure
;
Intubation, Intratracheal
4.Characteristics of changes in non-invasive hemodynamic parameters in neonates with septic shock.
Xiaoyi FANG ; Jinzhi XIE ; Airun ZHANG ; Guanming LI ; Silan YANG ; Xiaoling HUANG ; Jizhong GUO ; Niyang LIN
Chinese Critical Care Medicine 2025;37(1):29-35
OBJECTIVE:
To observe the characteristics of changes in non-invasive hemodynamic parameters in neonates with septic shock so as to provide clinical reference for diagnosis and treatment.
METHODS:
A observational study was conducted. The neonates with sepsis complicated with septic shock or not admitted to neonatal intensive care unit (NICU) of the First Affiliated Hospital of Shantou University Medical College were enrolled as the study subjects, who were divided into preterm infant (< 37 weeks) and full-term infant (≥ 37 weeks) according to the gestational age. Healthy full-term infants and hemodynamically stable preterm infants transferring to NICU after birth were enrolled as controls. Electronic cardiometry (EC) was used to measure hemodynamic parameters, including heart rate (HR), mean arterial pressure (MAP), stroke volume (SV), stroke volume index (SVI), cardiac output (CO), cardiac index (CI), systemic vascular resistance (SVR) and systemic vascular resistance index (SVRI), before treatment in the septic shock group, at the time of diagnosis of sepsis in the sepsis without shock group, and before the discharge from the obstetric department or on the day of transferring to NICU in the control group.
RESULTS:
Finally, 113 neonates with complete data and parental consent for non-invasive hemodynamic monitoring were enrolled, including 32 cases in the septic shock group, 25 cases in the sepsis without shock group and 56 cases in the control group. In the septic shock group, there were 17 cases at the compensated stage and 15 cases at the decompensated stage. There were 21 full-term infants (20 cured or improved and 1 died) and 11 premature infants (7 cured or improved and 4 died), with the mortality of 15.62% (5/32). There were 18 full-term infants and 7 premature infants in the sepsis without shock group and all cured or improved without death. The control group included 28 full-term infants and 28 premature infants transferring to NICU after birth. Non-invasive hemodynamic parameter analysis showed that SV, SVI, CO and CI of full-term infants in the septic shock group were significantly lower than those in the sepsis without shock group and control group [SV (mL): 3.52±0.99 vs. 5.79±1.32, 5.22±1.02, SVI (mL/m2): 16.80 (15.05, 19.65) vs. 27.00 (22.00, 32.00), 27.00 (23.00, 29.75), CO (L/min): 0.52±0.17 vs. 0.80±0.14, 0.72±0.12, CI (mL×s-1×m-2): 40.00 (36.67, 49.18) vs. 62.51 (56.34, 70.85), 60.01 (53.34, 69.68), all P < 0.05], while SVR and SVRI were significantly higher than those in the sepsis without shock group and control group [SVR (kPa×s×L-1): 773.46±291.96 vs. 524.17±84.76, 549.38±72.36, SVRI (kPa×s×L-1×m-2): 149.27±51.76 vs. 108.12±12.66, 107.81±11.87, all P < 0.05]. MAP, SV, SVI, CO and CI of preterm infants in the septic shock group were significantly lower than those in the control group [MAP (mmHg, 1 mmHg ≈ 0.133 kPa): 38.55±10.48 vs. 47.46±2.85, SV (mL): 2.45 (1.36, 3.58) vs. 3.96 (3.56, 4.49), SVI (mL/m2): 17.60 (14.20, 25.00) vs. 25.50 (24.00, 29.00), CO (L/min): 0.32 (0.24, 0.63) vs. 0.56 (0.49, 0.63), CI (mL×s-1×m-2): 40.01 (33.34, 53.34) vs. 61.68 (56.68, 63.35), all P < 0.05], while SVR and SVRI were similar to the control group [SVR (kPa×s×L-1): 1 082.88±689.39 vs. 656.63±118.83, SVRI (kPa×s×L-1×m-2): 126.00±61.50 vs. 102.37±11.68, both P > 0.05]. Further analysis showed that SV, SVI and CI of neonates at the compensation stage in the septic shock group were significantly lower than those in the control group [SV (mL): 3.60±1.29 vs. 4.73±1.15, SVI (mL/m2): 19.20±8.33 vs. 26.34±3.91, CI (mL×s-1×m-2): 46.51±20.34 vs. 61.01±7.67, all P < 0.05], while MAP, SVR and SVRI were significantly higher than those in the control group [MAP (mmHg): 52.06±8.61 vs. 48.54±3.21, SVR (kPa×s×L-1): 874.95±318.70 vs. 603.01±111.49, SVRI (kPa×s×L-1×m-2): 165.07±54.90 vs. 105.09±11.99, all P < 0.05]; MAP, SV, SVI, CO and CI of neonates at the decompensated stage in the septic shock group were significantly lower than those in the control group [MAP (mmHg): 35.13±6.08 vs. 48.54±3.21, SV (mL): 2.89±1.17 vs. 4.73±1.15, SVI (mL/m2): 18.50±4.99 vs. 26.34±3.91, CO (L/min): 0.41±0.19 vs. 0.65±0.15, CI (mL×s-1×m-2): 43.34±14.17 vs. 61.01±7.67, all P < 0.05], while SVR and SVRI were similar to the control group [SVR (kPa×s×L-1): 885.49±628.04 vs. 603.01±111.49, SVRI (kPa×s×L-1×m-2): 114.29±43.54 vs. 105.09±11.99, both P > 0.05].
CONCLUSIONS
Full-term infant with septic shock exhibit a low cardiac output, high vascular resistance hemodynamic pattern, while preterm infant with septic shock show low cardiac output and normal vascular resistance. At the compensated stage the hemodynamic change is low output and high resistance type, while at the decompensated stage it is low output and normal resistance type. Non-invasive hemodynamic monitoring can assist in the identification of neonatal septic shock and provide basis for clinical diagnosis and treatment.
Humans
;
Shock, Septic/physiopathology*
;
Infant, Newborn
;
Hemodynamics
;
Female
;
Male
;
Case-Control Studies
;
Infant, Premature
5.Design of portable respiratory device for transporting premature infants and application in the in-hospital transportation of extremely premature infants in primary hospitals.
Lijuan ZHANG ; Shuiqin GU ; Ping ZHENG ; Xiaoyi JI ; Huafei HUANG
Chinese Critical Care Medicine 2025;37(7):684-687
OBJECTIVE:
To design a portable respiratory device for transporting premature infants and explore its application effect in the in-hospital transportation of extremely premature infants in primary hospitals.
METHODS:
A prospective randomized controlled trial was conducted. The extremely premature infants born and transferred to neonatal intensive care unit (NICU) with oxygen therapy support from May to October in 2023 were selected and randomly divided into control group and observation group. The infants in the control group received respiratory support and in-hospital transportation using a traditional T-combination resuscitator connected to pure oxygen, and those in the observation group used a portable premature infant transport respiratory device designed and manufactured by medical staff to provide respiratory support and implement in-hospital transportation. The respiratory device for transporting premature infants is made of 304 stainless steel material, mainly consisting of a T-combination resuscitator, an air oxygen mixer, an air tank, a pure oxygen cylinder, a pressure reducing valve, a telescopic rod, a tray, a hook, a bottom plate, and four moving wheels, which can achieve precise control of the fraction of inspired oxygen (FiO2) during transportation. The achievement rate of first-time target pulse oxygen saturation (SpO2, achieving a target SpO2 of 0.90-0.95 was considered as meeting the standard) and arterial partial pressure of oxygen (PaO2) after being transferred to the NICU, as well as the manpower expenditure and time required for transportation of pediatric patients between the two groups were observed.
RESULTS:
A total of 73 extremely premature infants were enrolled, including 38 in the control group and 35 in the observation group. There was no significant difference in the gender, gestational age at birth, birth weight, mode of delivery, Apgar score at 1 minute and 5 minutes after birth, and oxygen therapy during the transportation between the two groups. The achievement rate of first-time target SpO2 after NICU in the observation group was significantly higher than that in the control group [94.29% (33/35) vs. 26.32% (10/38), P < 0.05], the PaO2 control range was better [mmHg (1 mmHg = 0.133 kPa): 85.50±6.36 vs. 103.00±2.83, P < 0.05], manpower expenditure and time required for transportation were significantly reduced [manpower expenditure (number): 2.14±0.35 vs. 3.17±0.34, time required for transportation (minutes): 10.42±0.76 vs. 15.54±0.34, both P < 0.05].
CONCLUSIONS
The portable respiratory device for transporting premature infants is used for respiratory support during the transportation of extremely premature infants in primary hospitals. It can improve the achievement rate of target SpO2, control PaO2 within the target range, and avoid hypoxia or hyperoxia during transportation. The breathing apparatus is compact, easy to carry, can save labor resources and time during transport, is cost-effective, and is suitable for widespread application in primary hospitals.
Humans
;
Infant, Newborn
;
Transportation of Patients
;
Prospective Studies
;
Equipment Design
;
Infant, Extremely Premature
;
Intensive Care Units, Neonatal
;
Infant, Premature
6.Clinical feature and genetic analysis of a preterm infant with Netherton syndrome due to variants of SPINK5 gene.
Lingling HU ; Canyang ZHAN ; Mingyu HAN ; Tianming YUAN ; Lihua CHEN
Chinese Journal of Medical Genetics 2025;42(3):330-335
OBJECTIVE:
To explore the clinical characteristics and genetic variant in a premature infant with Netherton syndrome (NS).
METHODS:
A neonate with NS caused by variants of SPINK5 gene diagnosed at the Children's Hospital Affiliated to Zhejiang University School of Medicine in March 2020 was selected as the study subject. Clinical data and family history were collected. Peripheral blood samples (2 mL each) were obtained from the child and her parents for whole-exome sequencing (WES). Candidate variants were subjected to pathogenicity classification and deleteriousness evaluation. This study has been approved by the Medical Ethics Committee of the Hospital (Ethics No. 2024-IRB-0251-P-01).
RESULTS:
The infant was born prematurely at 35+3 weeks due to "premature rupture of membranes for 4 hours" and exhibited generalized skin peeling, with meconium-stained amniotic fluid resembling bean curd residue. The condition improved with supportive treatments such as anti-infection and moisturizing therapy, though periodic hair loss had persisted. No similar case was reported by family history. WES has revealed a heterozygous c.1130delG (p.G377Efs*127) variant in exon 14 of the SPINK5 gene, which was inherited from her mother, and deletion of exons 1 ~ 33 of the SPINK5 gene, which was inherited from her father.
CONCLUSION
This case of NS presented with intrauterine onset in a preterm infant, which has not been previously reported. The identification of c.1130delG (p.G377Efs*127) variant has expanded the mutation spectrum of the SPINK5 gene.
Humans
;
Serine Peptidase Inhibitor Kazal-Type 5/genetics*
;
Netherton Syndrome/genetics*
;
Female
;
Infant, Newborn
;
Infant, Premature
;
Mutation
;
Exome Sequencing
;
Male
7.Research Progress in Effect of Repetitive Noxious Stimuli in Neonatal Period on Neural Development.
Yan LI ; Wen-Yu ZHANG ; Zhi XIAO ; Xing-Feng LIU
Acta Academiae Medicinae Sinicae 2025;47(5):843-849
The establishment and development of neonatal intensive care unit(NICU)have significantly increased the survival rate of premature infants.However,the diagnosis,treatment,and surgeries performed in NICU may expose neonates to more noxious stimuli.As the neonatal period is crucial for brain development,these noxious stimuli may cause irreversible damage to the neonatal nervous system.Existing clinical studies have shown that repetitive noxious stimuli during the neonatal period can lead to poor brain development,persistent hyperalgesia,and various sequelae.However,the underlying mechanisms remain unclear,and effective treatment methods are lacking.This article summarizes the effects of repetitive noxious stimuli during the neonatal period on neural development and the complications,aiming to provide a basis for the neonatal analgesia management and the prevention and treatment of related sequelae.
Humans
;
Infant, Newborn
;
Brain/growth & development*
;
Infant, Premature
;
Intensive Care Units, Neonatal
;
Hyperalgesia
;
Pain
8.Preterm birth trends and risk factors in a multi-ethnic Asian population: A retrospective study from 2017 to 2023, can we screen and predict this?
Rachel Phoy Cheng CHUN ; Hiu Gwan CHAN ; Gilbert Yong San LIM ; Devendra KANAGALINGAM ; Pamela PARTANA ; Kok Hian TAN ; Tiong Ghee TEOH ; Ilka TAN
Annals of the Academy of Medicine, Singapore 2025;54(5):296-304
INTRODUCTION:
Preterm birth (PTB) remains a leading cause of perinatal morbidity and mortality worldwide. Understanding Singapore's PTB trends and associated risk factors can inform effective strategies for screening and intervention. This study analyses PTB trends in Singapore from 2017 to 2023, identifies risk factors in this multi-ethnic population and evaluates a predictive model for PTB.
METHOD:
A retrospective analysis of all PTBs between 22+0 and 36+6 weeks of gestation, from 1 January 2017 to 31 December 2023, was performed by extracting maternal and neonatal data from electronic medical records. These PTBs were taken from the registry of births for Singapore and SingHealth cluster data. Cochran- Armitage trend test and multinomial logistic regression were used. An extreme gradient boosting (XGBoost) model was developed to test and predict the risk of PTB.
RESULTS:
The PTB rate in Singapore did not show a significant change. However, there was modest downward trend in the SingHealth population from 11.3% to 10.2%, mainly in late spontaneous PTBs (sPTBs). sPTBs accounted for ∼60% of PTBs. Risk factors for very/extreme sPTB included Chinese ethnicity, age ≥35 years, body mass index (BMI) ≥23 kg/m2, being unmarried, primiparity, twin pregnancy and maternal blood group AB. The XGBoost model achieved an area under the receiver operating characteristic curve of 0.75, indicating moderate ability to predict PTB.
CONCLUSION
The overall PTB rate in Singapore has not improved. This study underscores the importance of local factors, particularly advanced maternal age, BMI, primiparity, unmarried, Chinese ethnicity and maternal blood group AB influencing PTB risk. Artificial intelligence methods show promise in improving PTB risk stratification, ultimately supporting personalised care and intervention.
Humans
;
Singapore/epidemiology*
;
Retrospective Studies
;
Female
;
Risk Factors
;
Premature Birth/ethnology*
;
Pregnancy
;
Adult
;
Infant, Newborn
;
Asian People/statistics & numerical data*
;
Gestational Age
;
Body Mass Index
;
Maternal Age
;
Logistic Models
;
Ethnicity


Result Analysis
Print
Save
E-mail